Botulism food poisoning is caused primarily by ingestion of the Clostridium botulinum neurotoxin (BoNT). The 1300 amino acid BoNT forms a progenitor toxin (PTX) that, when associated with a number of other proteins, increases its oral toxicity by protecting it from the low pH of the stomach and from intestinal proteases. One of these associated proteins, HA1, has also been suggested to be involved with internalization of the toxin into the bloodstream by binding to oligosaccharides lining the intestine. Here is reported the crystal structure of HA1 from type C Clostridium botulinum at a resolution of 1?7 Å . The protein consists of two b-trefoil domains and bears structural similarities to the lectin B-chain from the deadly plant toxin ricin. Based on structural comparison to the ricin B-chain lactose-binding sites, residues of type A HA1 were selected and mutated. The D263A and N285A mutants lost the ability to bind carbohydrates containing galactose moieties, implicating these residues in carbohydrate binding.
INTRODUCTION
The botulinum neurotoxin (BoNT) produced by Clostridium botulinum is one of the most potent toxins known. Exposure to the toxin can result in botulism food poisoning leading to blepharoptosis, dysphasia followed by dyspnoea and finally death (Lund, 1990) . C. botulinum strains produce seven immunologically distinct neurotoxins labelled A-G (Sakaguchi et al., 1984) . Human botulism is primarily caused by the strains that produce toxin types A, B, E and F. Types C and D strains for the most part cause botulism only in non-human species (bovine, mink and bird) (Shapiro et al., 1998) . The neurotoxins (A-G) block the release of acetylcholine at neuromuscular junctions and synapses by cleaving protein components of the neuroexocytosis apparatus (Jahn & Niemann, 1994; Montecucco & Schiavo, 1994) . In culture fluids these neurotoxins associate with non-toxic components to form larger complexes that are designated progenitor toxins (PTXs). Three different sizes of PTXs are produced by type A strains: 19S toxin (900 kDa), 16S toxin (500 kDa) and 12S toxin (300 kDa). Type B, C and D strains produce both the 16S and the 12S toxins, whereas type E and F strains produce only the 12S toxin. The type G strain produces only the 16S toxin (Sakaguchi et al., 1984) . The non-toxic component of 12S toxin was characterized and shown to lack haemagglutination activity, while the 19S and 16S toxins were shown to contain the 12S toxin plus a haemagglutinin component (HA) consisting of four proteins: HA1, HA2, HA3a and HA3b (Fujinaga et al., 1994; Inoue et al., 1996) . Thus, the 19S and 16S toxins are referred to as HA-positive progenitor toxins (HA + -PTXs). The non-toxic components increase the oral toxicity of the neurotoxin by protecting the neurotoxin from the acidic condition in the stomach and protease digestion in the intestine (Sugii et al., 1977) . In addition to protecting the structural integrity of the neurotoxin, HA may increase the internalization of the neurotoxin into the bloodstream of the host (Fujinaga et al., 1997 (Fujinaga et al., , 2000 ; however, it is not clear which protein of the HA complex directly interacts with the neurotoxin. Depending on the strain (A-G), different components of HA may play more dominant roles. It has been demonstrated that HA of type C 16S toxin is involved in binding to the small intestine of guinea pigs through interactions with glycolipids and glycoproteins containing sialic acid moieties (Fujinaga et al., 1997; Inoue et al., 1999) . This binding ability has been attributed to HA3b (Fujinaga et al., 2000) . Type A HA + -PTX does not appear to bind carbohydrates containing sialic acid but instead binds mainly glycolipids and glycoproteins containing b-D-Gal-(1R4)-D-GlcNAc (N-acetyllactosamine). This recognition has been attributed to the HA1 component (Inoue et al., 2001) . These differences may contribute to strain specificity for a particular host.
To better understand how type A HA1 interacts with sugars and thus may be involved in internalization of the neurotoxin, the techniques of isothermal titration calorimetry (ITC) and protein crystallography have been employed. Although we were unable to obtain diffraction quality crystals of type A HA1, we were able to crystallize and determine the X-ray structure of type C HA1. Type C HA1 is 37 % identical in sequence to type A HA1 and thus should provide a good structural model for type A HA1. Type C HA1 consists of two b-trefoil domains and bears structural similarities to the crystal structure of the ricin B-chain with lactose bound. ITC analysis was successfully applied to characterize carbohydrate-binding specificity of type A HA1, suggesting a single binding site with preference for galactose (Gal) and oligosaccharides containing Gal at the non-reducing end. Based on the sequence alignment of type A HA1 to type C HA1 and the structural comparison of type C HA1 to the ricin B-chain lactose-binding sites, site-directed mutagenesis was performed on type A HA1 to determine the carbohydrate-binding site. ITC analysis of these mutants revealed that the D263A and N285A mutants completely abrogated carbohydrate binding, implicating these residues in carbohydrate binding.
METHODS
Expression and purification of type C HA1. Type C HA1 was amplified from a previously described template using the 59 PCR amplification primer 59-CCG CGT GGA TCC ATG TCT CAA ACA AAT GCA AAT-39 which adds a BamHI restriction site to the 59 end (Fujinaga et al., 1994; Tsuzuki et al., 1990 ). An XhoI site was added to the 39 end using the 39 PCR amplification primer 59-CGG CCG CTC GAG TTA TAT TAA ATT TAT AAT CAT-39. The PCR product was ligated into the pGEX-4T-3 vector (Amersham Pharmacia Biotech) containing the glutathione-S-transferase (GST) coding sequence using the BamHI and XhoI restriction sites. A 106histidine tag was inserted on the N-terminal end of HA1 (between GST and HA1), using the oligomers 59-GAT CCC ATC ATC ATC ATC ATC ATC ATC ATC ATC ATC ATA-39 and 59-GAT CTA TGA TGA TGA TGA TGA TGA TGA TGA TGA TGG-39. These oligomers were phosphorylated by polynucleotide kinase and annealed. The pGEX-4T-3 cloned with HA1 was treated with BamHI and ligated with annealed oligomers. The nucleotide sequence of the clone was determined using pGEX 59 and 39 primers and found to be identical to the published sequence.
The HA1-GST fusion protein was expressed in Escherichia coli BL21(DE3) cells (Invitrogen). The transformed bacteria were grown in Luria-Bertani (LB) medium containing 100 mg ampicillin ml 21 at 37 uC. Growth was monitored by optical density measurements at 600 nm; at an OD 600 value of 0?8, expression was induced with 0?1 mM IPTG. The cells were grown overnight at room temperature in 18 l of LB medium and harvested by centrifugation (5000 g, 20 min). Cells were resuspended in PBS, sonicated and spun down at 38 000 r.p.m. for 30 min at 4 uC. The supernatant was collected and incubated with Glutathione Sepharose 4B (Amersham Pharmacia Biotech) resin (1 ml resin per 1 l induced cell culture), equilibrated with PBS and shaken gently for 30 min at 4 uC. The resin was washed five times in batch with a volume of PBS 25 times that of the resin for each wash. The fusion protein was cleaved on the resin with 50 units of thrombin (Sigma) overnight at room temperature. The supernatant/ Sepharose mixture was poured into a column with a fritted filter and the resin was washed with PBS until the OD 280 value became less than 0?1. The eluted solution was applied to a Benzamidine Sepharose 6B (Amersham Pharmacia Biotech) column to remove thrombin. The resulting solution was collected and then applied onto a Ni-NTA agarose (Qiagen) column pre-equilibrated with 20 mM Tris/HCl (pH 7?5) containing 0?1 M NaCl. After washing the column with equilibration buffer, bound protein was eluted using a 0-500 mM imidazole gradient. Fractions that contained pure HA1 were pooled, dialysed against 20 mM MES (pH 5?5), concentrated to 25 mg ml 21 and stored at 280 uC.
Expression and purification of type A HA1. The expression vector pGEX-5X-3 type A HA1 constructed previously (Fujinaga et al., 2000) was used as a template. Primers 59-CCGCGTGGAT-CCATGGAACACTATTCAGTAATC-39 and 59-CGGCCGCTCGAG-TTATGGGTTACGAATATTCCA-39 were designed for amplification with PCR. The product was restricted with BamHI and XhoI and, after purification by agarose gel electrophoresis, was inserted into the expression vector pGEX-4T-3 and transformed into E. coli BL21(DE3) cells. Using a similar protocol as for type C HA1, the protein was expressed and then purified on Glutathione Sepharose 4B resin. The protein was eluted from the resin by overnight thrombin cleavage (6 units per millilitre of resin). The eluted protein was then dialysed overnight against 10 mM phosphate buffer, pH 5?5. All type A HA1 mutants were purified using the same protocol as the wild-type protein.
Site-directed mutagenesis of type A HA1. Site-directed mutagenesis was performed using the QuickChange Site-Directed Mutagenesis kit (Stratagene) following the protocols described in the accompanying instruction manual. The primers used were as follows: for D171A mutation, 59-GTCGTACAACAAGTGGCTGTG-ACAAATCTAAAT-39 and 59-ATTTAGATTTGTCACAGCCACTTG-TTGTACGAC-39; for N187A mutation, 59-TGGGACTATGGTCG-CGCTCAAAAATGGACAATT-39 and 59-AATTGTCCATTTTTGAG-CGCGACCATAGTCCCA-39; for D263A mutation, 59-ACAACTAA-AGCTCTAGCTTTATATGGCGGCCAA-39 and 59-TTGGCCGCC-ATATAAAGCTAGAGCTTTAGTTGT-39; for N285A mutation, 59-TATCATGGAGATGATGCTCAGAAATGGAATATT-39 and 59-AATATTCCATTTCTGAGCATCATCTCCATGATA-39. Sequences were confirmed, following mutagenesis, with the Big Dye Terminator Cycle Sequencing Reaction Kit (Applied Biosystems) in accordance with the protocol found in the accompanying instruction manual.
ITC. ITC measurements were carried out using a VP-ITC MicroCalorimeter (Micro Cal) at 30 uC. Solutions containing carbohydrate concentrations of 60 mM were injected into a reaction cell containing about 200 mM protein. Thirty injections of 6 ml at 180 s intervals were performed. Data acquisition and analyses were performed using the MICROCAL ORIGIN software package.
Crystallization of type C HA1. Crystals of type C HA1 were obtained using the vapour-diffusion hanging-drop method. Purified protein was mixed with equal volumes of a reservoir solution consisting of 0?1 M MES (pH 5?5), 100 mM MgCl 2 and 10 % PEG-8000 and placed above the reservoir. For data collection, harvested crystals were transferred to a cryoprotectant consisting of 0?1 M "Rcullis=S||F PH ±F P |2F Hcalc |/S|F PH ±F P |. #Phasing power=S<F h >/E, where <F h > is the root mean square heavy atom structure factor and E is the residual lack of closure error.
MES (pH 5?5), 100 mM MgCl 2 , 12 % PEG-8000 and 15 % ethylene glycol and then flash-frozen at the detector in a stream of nitrogen cooled to 2170 uC. Crystals were transferred to the cryosolution in four steps of increasing ethylene glycol and PEG concentration. For the HgCl 2 derivatized crystal, the crystal was soaked in the reservoir solution containing saturated HgCl 2 (<1 mM) overnight then backsoaked into the same cryoprotectant used for native crystals.
The higher resolution native dataset (native 2) was collected from a crystal soaked in the 11 mM tetra-saccharide lacto-N-neo-tetraose; however, no electron density was detected for the tetra-saccharide. All datasets were collected with an RAXIS IV area detector system with Yale/MSC mirrors using a RU3H Rigaku generator. Data were indexed and integrated with DENZO and scaled using SCALEPACK (Otwinowski & Minor, 1997) (Table 1) . Phases were obtained using the single isomorphous replacement with anomalous scattering (SIRAS) technique. SHELX was used to determine the position of the heavy metal sites (Sheldrick et al., 1993) , MLPHARE was used to calculate phases, and DM was used to improve the quality of the electron density map (Bailey, 1994) . Automated model building using WARP produced half of the model (Perrakis et al., 1999) . Two molecules were found in the asymmetric unit. Both molecules contain electron density for residues 4-286 out of the 286 expected and both have good geometry as determined by PROCHECK (Laskowski et al., 1993) . All programs, with the exception of DENZO and SCALEPACK, were from the CCP4 interactive package (Bailey, 1994) .
RESULTS AND DISCUSSION
Overall description of type C HA1 crystal structure
The crystal structure of type C HA1 is composed of two b-trefoil domains linked by an a-helix (McLachlan, 1979; Murzin et al., 1992; Notenboom et al., 2002; Rutenber et al., 1987) (Fig. 1a) . The b-trefoil fold consists of a sixstranded anti-parallel b-barrel capped on one end by three b-hairpins (Fig. 1a ). The formation of this structure is based on a repeating subdomain motif in which four b-strands, separated by three variable sized loops, come together to form two anti-parallel b-sheet fragments (Fig. 1b, c) . The first and fourth strands in this motif form part of the b-barrel, while the second and third strands form an independent b-hairpin. The three variablesized loops separating the four strands occasionally possess secondary structure elements, but generally exhibit no characteristic sequence or structure. While it is these three loops that lend the name 'trefoil' to the fold, it is understandably easy to confuse the name with the fact that three of these motifs are repeated around a pseudo-threefold Each secondary structural element is labelled. These images were created using MOLSCRIPT and RASTER3D (Kraulis, 1991; Merritt & Bacon, 1997) .
axis to form the entire b-trefoil domain (Fig. 1b) . The three motifs are termed a-, b-and c-repeats in sequence from the N-to the C-terminal end of the domain.
In the type C HA1 structure presented here, the first or N-terminal b-trefoil domain is made up of residues 4-141 and the second, C-terminal b-trefoil is made up of residues 146-286. The two domains are connected by a short a-helix (Fig. 1a) . Superposition of the two b-trefoils reveals a root mean square deviation of 1?4 Å for 121 common Ca atoms. Based on this structural alignment, the two domains share 22 % sequence identity, suggesting that the protein is the result of gene duplication as has been suggested for other proteins containing two b-trefoil domains (Rutenber et al., 1987; Transue et al., 1997) .
The b-trefoil domain is a structural fold found in other proteins including lectins such as the ricin B-chain (Rutenber et al., 1987) and Amaranthus caudatus agglutinin (ACA) (Transue et al., 1997) , cytokines such as fibroblast growth factor (FGF) (Faham et al., 1996; Ornitz et al., 1995; Zhang et al., 1991) and interleukin-1 (IL-1) (Finzel et al., 1989) , Kunitz trypsin inhibitors such as that from soybean (Sweet et al., 1974) , the actin cross-linking protein hisactophilin (Habazettl et al., 1992) , the xylan-binding domain of xylanase 10A (XBD-10A) (Notenboom et al., 2002) , the cysteine-rich domain of the mannose receptor (Liu et al., 2000) , and even in the BoNT structures (Lacy et al., 1998; Swaminathan & Eswaramoorthy, 2000) . In many instances, the b-trefoil domain acts as an oligosaccharide-binding unit supporting the suggestion that the b-trefoil fold itself is a result of a gene triplication of an ancient carbohydratebinding peptide (the four-strand trefoil motif) of approximately 40 residues (Rutenber et al., 1987) .
Position, orientation and interactions between b-trefoil domains and carbohydrates vary among different proteins.
In the case of ligand binding to the BoNT/B protein, the majority of the interactions between the protein and the sialylactose ligand are with the sialic acid substituent (Swaminathan & Eswaramoorthy, 2000) . Binding of a substituent also dictates carbohydrate binding to the cysteinerich domain of the mannose receptor where the majority of the interactions between ligand and protein are backbone amides forming hydrogen bonds with a sulfate moiety (Liu et al., 2000) . In addition, sulfate moieties are responsible for heparan sulfate binding to the FGF1 b-trefoil protein.
In the crystal structure of the FGF1-FGFR2-heparan sulfate complex, the heparan sulfate molecule binds two FGF1s to create the FGF1 dimer required for binding to the FGFR2 (Pellegrini et al., 2000) . The non-toxic plant lectin ACA, like HA1, contains two b-trefoils per subunit. This protein is a dimer in solution even when carbohydrate is not bound. ACA contains two sugar-binding sites specific for the T-disaccharide [b-D-Gal-(1R3)-D-GalNAc] and related by dimer symmetry. The 1b-and 1c-repeats from one molecule and the 2c-repeat from the dimer-related molecule make contacts with the flat sides of the sugars to make up one binding site (Transue et al., 1997) .
Lactose binding to b-trefoil domains has been observed in the ricin B-chain and the XBD-10A structures (Notenboom et al., 2002; Rutenber & Robertus, 1991) . Like HA1 and ACA, the ricin B-chain comprises two b-trefoil domains. In this structure, each of the b-trefoil domains (1a and 2c sites) binds one lactose molecule (Rutenber & Robertus, 1991) . In both cases the Gal moiety forms hydrogen bonds with an Asp from b-strand 2 of the repeat, an Asn from just before b-strand 4 of the repeat, and forms van der Waals contacts with an aromatic residue from b-strand 3 of the repeat. Similar binding is also seen with lactose binding to XBD-10A (Notenboom et al., 2002) . The XBD-10A structure is a single b-trefoil that binds lactose by the Gal sugar at the a and c positions in a manner similar to lactose binding to ricin B-chain. Interestingly, the reducing glucose sugar protruding from the c-repeat is seen binding to the b-repeat of a crystal symmetry-related XBD-10A molecule. Thus, lactose is found binding at all three sites in the crystal structure.
ITC analysis of carbohydrate binding to type A HA1
Previous work demonstrated that lactose inhibited haemagglutinin activity of type A HA1 (Inoue et al., 2001) , therefore ITC was utilized to investigate lactose binding to type A HA1. The heat released was measured during successive injections of lactose solution, and the integrated heats of binding were plotted against the molar ratio of lactose and type A HA1 to generate a binding isotherm. From this, the stoichiometry, affinity (dissociation constant K d ), entropy (DS) and enthalpy (DH) of the binding were determined. Heat was released as an indication of the . This orientation is based on positioning the 2c-repeat in the same orientation as the 1a-repeat in (a). Superposition is based on 115 structurally equivalent Cas with a root mean square deviation of 1?8 Å . These images were created using MOLSCRIPT and RASTER3D (Kraulis, 1991; Merritt & Bacon, 1997) .
binding of b-lactose to the type A HA1 protein ( Fig. 2a ). However, no heat was released either when lactose solution was successively injected into the buffer solution without type A HA1 (Fig. 2b) or when BSA was used instead of type A HA1 (data not shown). The stoichiometry of the heat release suggests that type A HA1 has a single binding site per molecule.
Binding studies with different mono-and oligosaccharides were performed and the results are summarized in Table 2 . Only Gal or oligosaccharides containing Gal at the non-reducing end bound to type A HA1. The K d values of HA1 to a-and b-lactoses were almost identical and the lowest among carbohydrates tested (Table 2) . Gal, Nacetylgalactosamine and a-D-Gal-(1R3)-b-D-Gal-(1R4)-GlcNAc possessed slightly higher K d values, followed by a-D-Gal-(1R3)-D-Gal and stachyose tetrahydrate. The other carbohydrates glucose, fructose, glucuronic acid and N-acetylglucosamine did not bind to HA1 (Table 2) .
Ligand-binding site of type A HA1
Given the preference for lactose by type A HA1, it is possible that for at least type A, HA1 binding of carbohydrates could be more similar to ricin B-chain than to other b-trefoil-containing proteins. Based on 37 % sequence identity between type A HA1 and type C HA1, structurally these proteins are likely to be very similar. To determine which residues of type A HA1 may be interacting with carbohydrates, superpositions of type C HA1 domains were made to those of the ricin B-chain (Fig. 3a, b) . These superpositions were then used to produce structural alignments of the repeats between ricin B-chain and type C HA1. Type A and B HA1 were then aligned based on sequence to type C HA1 (Fig. 4 ). From this figure it is observed that there are four conserved residues in ricin B-chain that form interactions with lactose in both the 1a-and 2c-repeats. All the interactions between the ricin B-chain and the lactose molecules are with the Gal sugar. The conserved Asp residues (D22 from 1a, D234 from 2c) from b-strand 2 and the Asn residues (N46 from 1a, N255 from 2c) just prior to b-strand 4 form hydrogen bonds with the Gal, while the conserved aromatic residues (W37 from 1a, Y248 from 2c) from b-strand 3 are likely involved in van der Waals contacts. Also conserved are Gln residues (Q47 from 1a, Q256 from 2c) just after the conserved Asn residues that forms hydrogen bonds with the conserved Asp. Fig. 4 . Sequence alignments of the a-, b-and c-repeats from type C HA1 domains with those of the ricin B-chain and with type A and B HA1 (type D HA1 is 100 % identical in sequence to C). Ricin B-chain and type C HA1 alignments are based on common residues (dark-grey boxes) after superposing each domain. Alignments of type A and B HA1 are based on sequence comparison to the type C protein. Grey columns define approximate residues of the four b-strands that comprise each repeat. The last seven residues in the 1c row of HA1 (boxed) represent the a-helical linker between the two domains. Residues known to contact carbohydrate in ricin are marked with asterisks.
In the 1a site an additional residue, Gln45, also forms a hydrogen bond with the Gal. Although there are only two repeats in the ricin B-chain that interact with lactose, based on the structure, there is a possible binding site at each of the six repeats (1a, 1b, 1c, 2a, 2b and 2c).
For type C HA1, the 1a-repeat is a likely candidate for carbohydrate binding. The conserved Asp, Trp, Asn and Gln from the ricin B-chain are all present in this repeat (Fig. 4) . Interestingly, a molecule of ethylene glycol used as a cryoprotectant for data collection is found binding in the 1a site of HA1 (Fig. 5a ). Previously, it has been demonstrated that the cryoprotectant glycerol (which structurally is very similar to ethylene glycol) binds in two of the three lactose-binding sites in the b-trefoil domain of the XBD-10A (Notenboom et al., 2002) . This supports the suggestion that these compounds are good at mimicking carbohydrate binding to b-trefoil domains. The ethylene glycol molecule in type C HA1 superposes almost exactly with the O-3, C-3, C-4 and O-4 atoms of the Gal seen in the ricin B-chain structure. This suggests that this region in type C HA1 may accommodate its yet unidentified carbohydrate of specificity in much the same manner as observed for the ricin B-chain. For type A HA1, conservative substitutions exist at the conserved Asp (Gln) and Trp (Phe) sites in the 1a-repeat. However, the Leu at the conserved Asn site suggests this may not be a carbohydrate-binding site. Although both types A and C HA1 contain the conserved Asn at the 1b site, neither has the conserved Asp or Trp residues, making this an unlikely binding site for either. In addition, the only conserved residue for either type A or C HA1 in the 1c-repeat is the conserved Asn in type C HA1. Although type C HA1 only has the conserved Trp in the 2a-repeat, type A HA1 contains the conserved Asn residue and conservative substitutions at the Asp (Gln) and Trp (Tyr) sites, making this a possible site for binding. Neither protein contains any conserved residues in the 2b-repeat; however, both show strong possibilities for binding at the 2c-repeat. Type C HA1 contains the conserved Asp and Asn residues as well as an additionally conserved Gln after the Asn. Fig. 5(b) displays a superposition of type C HA1 2c residues with those of ricin B-chain involved in making contacts with Gal. The 2c lactose-binding site of the ricin B-chain (D234 and N255) appears to be conserved and superposes well with D256 and N278 (respectively) of type C HA1 (Fig. 5b) . Type A HA1 contains these same conserved residues as type C, plus a conservative substitution of Phe at the Trp position and the additional Gln found hydrogen-bonding to Gal in the 1a-repeat of the ricin B-chain.
Because we do not know the specific ligand for type C HA1, it makes it difficult to test the possible binding sites based on the crystal structure. However, using site-directed mutagenesis and ITC analysis, we have tested for carbohydrate binding to type A HA1 at the 2a and 2c sites which showed the highest sequence similarity to conserved residues interacting with lactose in the ricin B-chain binding sites ( Table 3) . Substitution of an Ala for the conserved Asn in the 2a-repeat (N187A) had no significant effect on the ability to bind lactose. However, both the D263A and N285A mutants at the 2c-repeat abrogated lactose binding to type A HA1. This is consistent with the results of the ITC data that suggested one binding site for type A HA1. These results suggest that for type A HA1 the 2c-repeat is involved in carbohydrate binding. Fig. 3(a, b) . These figures were created using MOLSCRIPT and RASTER3D (Kraulis, 1991; Merritt & Bacon, 1997) . 
Final remarks
Although we have not yet obtained the crystal structure of a type C or a type A HA1 carbohydrate-bound complex, by comparing the crystal structure of type C HA1 to other lectins containing b-trefoil domains, and using ITC analysis coupled with site-directed mutagenesis, we have mapped the carbohydrate-binding site of type A HA1 to the 2crepeat. These results provide solid evidence that at least one of HA1's roles in the PTX is to bind oligosaccharides (Inoue et al., 2001) , supporting the hypothesis that HA1 may aid in internalization from the intestine of the BoNT.
